What the notice covers
The National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 2) 2026 is a government notice about a floor price amendment for certain pharmaceutical brands under the National Health Act 1953. It is administered by the Department of Health, Disability and Ageing.
The notice, identified as F2026N00276, was in force from 28 April 2026 to 1 October 2026 and has since been repealed.
What information is available
The source page only shows the document's administrative details - name, commencement, authority and schedules. It does not provide the specific drug brands, dollar amounts, or pricing details affected.
This is a pharmaceutical pricing matter administered at the federal health department level and does not contain information relevant to general small business compliance obligations.
Key actions
- If a pharmacy or other business is affected by PBS floor pricing, the full legislation text can be viewed at https://www.legislation.gov.au/F2026N00276 to check the specific brands and prices covered.
- This instrument is no longer in force, as it was repealed after 1 October 2026. Any replacement instrument should be checked if this pricing matter affects the business.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.